These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33449527)

  • 41. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases.
    Cho HJ; Kim YJ
    Methods Find Exp Clin Pharmacol; 2009 Apr; 31(3):171-6. PubMed ID: 19536360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The efficacy of divasa in the early recovery period of ischemic stroke].
    Mudrova OA; Schekolova NB; Borikov FA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(3 Pt 2):48-54. PubMed ID: 27296802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial.
    Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H
    J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry.
    Mazya MV; Lees KR; Collas D; Rand VM; Mikulik R; Toni D; Wahlgren N; Ahmed N
    Neurology; 2015 Dec; 85(24):2098-106. PubMed ID: 26546630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The efficacy of cortexin and memantinol (memantine) in the treatment of cognitive impairment in patients with chronic cerebral ischemia].
    Fedin AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):30-36. PubMed ID: 29460902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial.
    Shyu WC; Lin SZ; Lee CC; Liu DD; Li H
    CMAJ; 2006 Mar; 174(7):927-33. PubMed ID: 16517764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Characteristics of ischemic stroke according to hospital register data: a role of neuroreparative therapy].
    Kulesh AA; Shestakov VV; Syromyatnikova LI; Kravtsova EY; Bokov KN; Dementyeva OV; Selezneva SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):74-78. PubMed ID: 26356518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
    Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke.
    Wang H; Li X; Liu C; Huang S; Liang C; Zhang M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104829. PubMed ID: 32689578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive value of the NIHSS for ADL outcome after ischemic hemispheric stroke: does timing of early assessment matter?
    Kwakkel G; Veerbeek JM; van Wegen EE; Nijland R; Harmeling-van der Wel BC; Dippel DW;
    J Neurol Sci; 2010 Jul; 294(1-2):57-61. PubMed ID: 20439108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients.
    Clark WM; Wechsler LR; Sabounjian LA; Schwiderski UE;
    Neurology; 2001 Nov; 57(9):1595-602. PubMed ID: 11706098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome and safety assessment of an herbal medicine treatment protocol for yin pattern of acute ischemic stroke.
    Huang Y; Guo JW;
    Zhong Xi Yi Jie He Xue Bao; 2010 May; 8(5):417-26. PubMed ID: 20456839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials.
    Bornstein NM; Guekht A; Vester J; Heiss WD; Gusev E; Hömberg V; Rahlfs VW; Bajenaru O; Popescu BO; Muresanu D
    Neurol Sci; 2018 Apr; 39(4):629-640. PubMed ID: 29248999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)].
    Stakhovskaya LV; Shamalov NA; Khasanova DR; Melnikova EV; Agafiina AS; Golikov KV; Bogdanov EI; Yakupova AA; Roshkovskaya LV; Lukinykh LV; Lokshtanova TM; Poverennova IE; Shepankevich LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3. Vyp. 2):55-65. PubMed ID: 28665371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The effect of cellex on regenerative processes in cerebral parenchymal hemorrhage under experimental condition].
    Korsunskaya LL; Vlasenko SV; Davydova AA; Larina NV; Golubova TF; Muratova LR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(7):73-77. PubMed ID: 30132461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of antioxidant therapy on neurotrophins and processes of rehabilitation after stroke].
    Karakulova YV; Selyanina NV; Zhelnin AV; Filimonova TA; Cepilov SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):36-39. PubMed ID: 27635609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Results of evaluation of the effectiveness of the drug Cellex in patients with small vessel disease].
    Kamchatnov PR; Abusueva BA; Khanmurzaeva SB; Mityaeva EV; Chipova DT; Malashenkov ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(1):67-74. PubMed ID: 36719121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study.
    Chabriat H; Bassetti CL; Marx U; Picarel-Blanchot F; Sors A; Gruget C; Saba B; Wattez M; Audoli ML; Hermann DM
    Trials; 2020 Feb; 21(1):136. PubMed ID: 32014032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.